Tissue Genetics Inc. is a molecular diagnostics company with technology for improving the diagnosis, treatment and prevention of genetic diseases. The firm's proprietary biomarkers and novel test methods allow clinicians to diagnose genetic diseases fast, easily, accurately and economically. The objective is to establish a new paradigm for screening of genetic diseases, providing critical information for determining the patientsâ optimum course of care. The firm's diagnostic tests include proprietary, monoclonal antibodies for immunohistochemistry (IHC) screening to visualize the protein product of the gene, specifically to detect a protein truncation
